| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 5.6 | 0.0004 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.009 |